[1]陆荣,石舟红*,戴建荣,等.细胞学检查联合高危型人乳头瘤病毒在宫颈癌早期筛查中的价值分析[J].中国计划生育和妇产科,2019,(11):48-51.
　LU Rong,SHI Zhou-hong*,DAI Jian-rong,et al.Value of TCT combined with high-risk HPV in screening of early cervical cancer[J].Chinese Journal of Family Planning & Gynecotokology,2019,(11):48-51.
点击复制

细胞学检查联合高危型人乳头瘤病毒在宫颈癌早期筛查中的价值分析
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2019年11期
页码:
48-51
栏目:
论著与临床
出版日期:
2019-11-25

文章信息/Info

Title:
Value of TCT combined with high-risk HPV in screening of early cervical cancer
作者:
陆荣; 石舟红*; 戴建荣; 侯顺云
南京医科大学附属苏州医院妇科
Author(s):
LU Rong; SHI Zhou-hong*; DAI Jian-rong; HOU Shun-yun
Department of Gynecology，Suzhou Hospital Affiliated to Nanjing Medical University，Suzhou Jiangsu 215002，P.R.China
关键词:
宫颈癌; 早期筛查; TCT; 高危HPV
Keywords:
cervical cancer;  early screening;  TCT; high risk HPV
分类号:
R 713.4
摘要:
目的比较高危型人乳头瘤病毒（human papillomavirus，HPV）检测、薄层液基细胞学检查（thinprep cytologic test，TCT）以及高危HPV联合TCT在宫颈癌早期筛查中的价值。方法选取2017年3月至2019年3月在南京医科大学附属苏州医院门诊行妇科体检的女性928例，经过组织病理学证实明确分级。取宫颈细胞样本，进行TCT和高危HPV检测。对TCT、高危HPV以及二者联合检测的阳性率进行比较分析。结果在928例样本中，病理学诊断与高危HPV诊断的阳性率之间差异有统计学意义
Abstract:
ObjectiveTo compare the value of high risk human papillomavirus（HPV）detection, thinprep cytologic test (TCT）, high risk HPV combined with TCT in early cervical cancer screening. MethodsA total of 928 women who underwent gynecological examinations at the

参考文献/References:

［1］FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 ［J］. International Journal of Cancer. Journal International du Cancer, 2015, 136(5): E 359-E 386. ［2］BURK R D, CHEN Z, SALLER C, et al. Integrated genomic and molecular characterization of cervical cancer ［J］. Nature, 2017, 543(7645): 378-384. ［3］PHALIWONG P, PARIYAWATEEKUL P, KHUAKOONRATT N, et al. Cervical cancer detection between conventional and liquid based cervical cytology:a 6-year experience in northern Bangkok Thailand ［J］. Asian Pacific Journal of Cancer Prevention : APJCP, 2018, 19(5): 1331-1336. ［4］KOLIOPOULOS G, NYAGA V N, SANTESSO N A, et al. Cytology versus HPV testing for cervical cancer screening in the general population ［J］. Cochrane Database of Systematic Reviews, 2017, 8(8): CD008587. ［5］LEE E A, SHIN J, HWANG E J, et al. Breast and cervical cancer screening behavior in female cancer survivors: the Korea National health and nutrition examination survey, 2007-2012 ［J］. Korean Journal of Family Medicine, 2017, 38(3): 116-121. ［6］KITCHENER H C, CASTLE P E, COX J T. Achievements and limitations of cervical cytology screening ［J］. Vaccine, 2006, 24(3): 63-70. ［7］KIM J J, BURGER E A, SY S, et al. Optimal cervical cancer screening in women vaccinated against human papillomavirus ［J］. Journal of the National Cancer Institute, 2017, 109(2): djw216. ［8］SHANNON B, YI T-j, PERUSINI S, et al. Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota ［J］. Mucosal Immunology, 2017, 10(5): 1310-1319. ［9］NIEMINEN P, VUORMA S, VIIKKI M, et al. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer ［J］. BJOG-An International Journal of Obstetrics and Gynaecology, 2004, 111(8): 842-848. ［10］MAYRAND M H, DUARTE-FRANCO E, RODRIGUES I, et al. Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer ［J］. The New England Journal of Medicine, 2007, 357(16): 1579-1588. ［11］TOTA J E, BENTLEY J, BLAKE J, et al. Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm ［J］. Preventive Medicine, 2017, 98 (SI): 5-14. ［12］POLMAN N J, VELDHUIJZEN N J, HEIDEMAN D A, et al. HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test ［J］. British Journal of Cancer, 2017, 117(10): 1557-1561.

相似文献/References:

[1]冯学宇,乔银川,王好宁,等.823例宫颈癌机会性筛查结果分析[J].中国计划生育和妇产科,2010,(01):0.
　FENG Xue-yu,QIAO Yin-chuan,WANG Hao-ning ..[J].Chinese Journal of Family Planning & Gynecotokology,2010,(11):0.
[2]刘佳汭.保留盆腔自主神经的宫颈癌根治性手术[J].中国计划生育和妇产科,2010,(02):0.
[3]甘玉杰,熊小英,蔡春芳,等.血清SCCA、CA125、CA19-9与高危型人乳头状瘤病毒在宫颈癌及癌前病变中的表达及意义[J].中国计划生育和妇产科,2010,(04):0.
　GAN Yu-jie,XIONG Xiao-ying,CAI Chun-fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(11):0.
[4]肖春燕,陈桂珍,铁木帅龙,等.325例宫颈病变阴道镜检查结果分析[J].中国计划生育和妇产科,2010,(05):0.
　XIAO Chun-yan,CHEN Gui-zhen,TIEMU-Shuailong.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(11):0.
[5]钟茜,赵霞.宫颈癌诊治中的过度治疗与治疗不足[J].中国计划生育和妇产科,2013,(02):0.
　ZHONG Xi,ZHAO Xia,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(11):0.
[6]安红梅,张雯,邓继红,等.昆明地区高危HPV病毒载量与宫颈病变和宫颈癌相关性[J].中国计划生育和妇产科,2013,(03):0.
　AN Hong - mei,ZHANG Wen,DENG Ji - hong *,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(11):0.
[7]闵爱萍,谢桂清,冷开容,等.Hepsin、Maspin在宫颈疾病中的表达及其临床意义[J].中国计划生育和妇产科,2013,(06):0.
　Min Ai-ping,Xie Gui-qing,Leng Kai-rong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(11):0.
[8]朱书力,李力.树突状细胞对宫颈癌作用的研究进展[J].中国计划生育和妇产科,2014,(03):0.
[9]闵爱萍.刺猬蛋白在宫颈癌组织中的表达及其临床意义[J].中国计划生育和妇产科,2014,(07):0.
　MIN Ai-ping,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(11):0.
[10]孙肖霞,王志莲,郝敏,等.胰岛素样生长因子轴与宫颈癌的相关性研究[J].中国计划生育和妇产科,2015,(05):0.

备注/Memo

备注/Memo:
苏州市卫生局科技项目（项目编号：lczx201410）
更新日期/Last Update: 2019-11-25